Parenteral Anticoagulant Therapy: Implications for Patient Management


About Course #N1712

Release Date: June 17, 2016

Expiration Date: June 30, 2019

Anticoagulants are central to the management of cardiovascular and thrombotic conditions. Parenteral anticoagulants are particularly important in acute care situations given their fast onset of action. They are indicated for the management of acute coronary syndromes (ACS), in the treatment and prevention of venous thromboembolism (VTE), and in the management of heparin-induced thrombocytopenia (HIT). With the variety of oral anticoagulants now available, it is also important that advanced practice registered nurses (APRNs) recognize the changing role of parenteral anticoagulants when the indications overlap with those of oral therapy. Furthermore, they must be able to safely transition patients from parenteral to oral anticoagulants.

This course is designed for APRNs who are involved in decision making for parenteral anticoagulant selection or who provide care for patients who have already been prescribed a parenteral anticoagulant. The purpose of this course is to increase APRNs' knowledge of parenteral anticoagulants so that they can identify patients in whom therapy is indicated, assist in selecting the most appropriate option, and monitor and counsel the patient.

The focus of this course is on parenteral anticoagulants, their most pertinent prescribing information, and strategies for effective patient monitoring and counseling. This course begins with an overview of current practice guidelines for VTE prevention and treatment, HIT, and ACS. Then, an overview of the prescribing information for each associated parenteral anticoagulant follows, including strategies for reversal, patient monitoring, and counseling when applicable.

This course is an extract of, and should not be taken in conjunction with course #N1752 - Anticoagulant, Antiplatelet, and Thrombolytic Therapies: Implications for Advanced Practice Nursing.

About the Author(s)

Orthopedic Nurses - ONCB has approved this course for 2.25 Category A contact hours and .75 Category B contact hours toward recertification

Diana M. Sobieraj, PharmD, BCPS, earned her doctor of pharmacy degree from the University of Rhode Island and subsequently completed a pharmacy practice residency at Hartford Hospital/The University of Connecticut (UCONN) School of Pharmacy. After her training, Dr. Sobieraj joined the faculty at UCONN School of Pharmacy, where she has worked for the past 8 years. Currently, Dr. Sobieraj is an assistant professor in the Department of Pharmacy Practice in the tenure track. Her scholarly interests focus on comparative effectiveness and health outcomes research of anticoagulants and the treatment and prevention of thrombosis.

Course Disclosures

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.

  • bvseo_sdk, p_sdk, 3.2.0
  • CLOUD, getContent, 100.94ms
  • bvseo-msg: HTTP status code of 404 was returned;